Thomas Scarlett

Tom Scarlett has been an investment analyst for more than 20 years. He has written for Personal Finance, Utility Forecaster, Forecast and Strategies, Global Investing and other publications. He has also been an editor at Bloomberg BNA and Thompson Publishing.

Recent Articles By The Author

Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions

Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions

The pharmaceutical company's new strategy emphasizes new product launches and international expansion.

Oilfield Services Company Schlumberger Is Poised to Remain on Top

Oilfield Services Company Schlumberger Is Poised to Remain on Top

The world's leading company in its sector shows no signs of relinquishing its position and continues to flex its muscles.

Data Storage Provider Seagate's Adaptability Leading to Increased Profits

Data Storage Provider Seagate's Adaptability Leading to Increased Profits

Many remote servers that are critical to cloud computing systems rely on Seagate techology.

Regardless of Judge's Decision on Humana Deal, Aetna Is Pointing Upward

Regardless of Judge's Decision on Humana Deal, Aetna Is Pointing Upward

U.S. District Court Judge John Bates, a Republican appointee, is scheduled to rule on Aetna's proposed $37 billion acquisition of rival Humana later this month.

Drugstore Chain CVS Poised for a Rebound

Drugstore Chain CVS Poised for a Rebound

CVS has cash on hand and is benefiting from recent acquisitions.